The E-cadherin repressor snail plays a role in tumor progression of endometrioid adenocarcinomas
- PMID: 18043286
- DOI: 10.1097/PDM.0b013e31806219ae
The E-cadherin repressor snail plays a role in tumor progression of endometrioid adenocarcinomas
Abstract
Endometrial cancer is the most common gynecologic cancer in the developed world. The cell-adhesion protein E-cadherin acts as a tumor-suppressor protein and is down-regulated by the transcription factor Snail, whose expression was shown to be associated with estrogen receptor signaling. This study aimed to investigate the expression of E-cadherin, Snail, and estrogen-receptor alpha in 87 primary tumors and 26 metastases of endometroid endometrial carcinomas. Reduced E-cadherin immunoreactivity was seen in 44.8% of the primary tumors and 65.4% of the metastases with a statistical correlation to higher tumor grade (P=0.003) only in metastatic lesions. About 28.7% of primary tumor specimens showed a positive Snail immunoreactivity that was correlated with reduced estrogen-receptor alpha expression (P=0.047). Positive Snail immunoreactivity was also seen in 53.8% of the metastases where it was correlated with higher tumor grade (P=0.003) and abnormal E-cadherin expression (P=0.003). Interestingly, a Snail expressing endometrial carcinoma-cell line showed a higher migration potential than a variant of this cell line with low levels of Snail. Taken together, our data are in line with a proposed role for Snail in endometrial tumor progression.
Similar articles
-
Prognostic implications of epithelial to mesenchymal transition related proteins (E-cadherin, Snail) and hypoxia inducible factor 1α in endometrioid endometrial carcinoma.Ann Diagn Pathol. 2016 Jun;22:1-11. doi: 10.1016/j.anndiagpath.2016.01.004. Epub 2016 Feb 23. Ann Diagn Pathol. 2016. PMID: 27180053
-
Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype.Mod Pathol. 2002 Oct;15(10):1032-7. doi: 10.1097/01.MP.0000028573.34289.04. Mod Pathol. 2002. PMID: 12379748
-
Comparison of E-cadherin with STAT3 and apoptosis regulators: Bak and Bcl-xL in endometrioid adenocarcinomas of different ER-alpha immunoprofile.Gynecol Endocrinol. 2018 Feb;34(2):171-174. doi: 10.1080/09513590.2017.1379494. Epub 2017 Sep 22. Gynecol Endocrinol. 2018. PMID: 28937296
-
Tumor budding and E-Cadherin expression in endometrial carcinoma: are they prognostic factors in endometrial cancer?Gynecol Oncol. 2012 Apr;125(1):208-13. doi: 10.1016/j.ygyno.2011.12.433. Epub 2011 Dec 22. Gynecol Oncol. 2012. PMID: 22198340
-
Analysis of the E-cadherin repressor Snail in primary human cancers.Cells Tissues Organs. 2007;185(1-3):204-12. doi: 10.1159/000101321. Cells Tissues Organs. 2007. PMID: 17587826 Review.
Cited by
-
Endometrial Cancer-Adjacent Tissues Express Higher Levels of Cancer-Promoting Genes than the Matched Tumors.Genes (Basel). 2022 Sep 8;13(9):1611. doi: 10.3390/genes13091611. Genes (Basel). 2022. PMID: 36140779 Free PMC article.
-
Snail regulates Nanog status during the epithelial-mesenchymal transition via the Smad1/Akt/GSK3β signaling pathway in non-small-cell lung cancer.Oncotarget. 2014 Jun 15;5(11):3880-94. doi: 10.18632/oncotarget.2006. Oncotarget. 2014. PMID: 25003810 Free PMC article.
-
The genomics and genetics of endometrial cancer.Adv Genomics Genet. 2012 Mar;2012(2):33-47. doi: 10.2147/AGG.S28953. Adv Genomics Genet. 2012. PMID: 22888282 Free PMC article.
-
By inhibiting snail signaling and miR-23a-3p, osthole suppresses the EMT-mediated metastatic ability in prostate cancer.Oncotarget. 2015 Aug 28;6(25):21120-36. doi: 10.18632/oncotarget.4229. Oncotarget. 2015. PMID: 26110567 Free PMC article.
-
Activation of epidermal growth factor receptor results in snail protein but not mRNA overexpression in endometrial cancer.J Cell Mol Med. 2009 Sep;13(9B):3858-67. doi: 10.1111/j.1582-4934.2008.00526.x. Epub 2008 Oct 13. J Cell Mol Med. 2009. PMID: 19604315 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials